Skip to main content
DIRECTA PLUS PLC logo

DIRECTA PLUS PLC — Investor Relations & Filings

Ticker · DCTA ISIN · GB00BSM98843 LEI · 213800X2DQST3K5ND898 IL Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2020-04-14 Regulatory Filings
Country GB United Kingdom
Listing IL DCTA

About DIRECTA PLUS PLC

https://www.directa-plus.com/

Directa Plus PLC is a producer and supplier of engineered graphene nanoplatelets-based products. The company has developed a proprietary, patented, and chemical-free manufacturing process that is scalable and sustainable, designed to meet the quality and volume requirements of large industrial supply chains. Its core product, G+® Graphene Plus, is a material used to enhance the performance of commercial and industrial products. Key applications include performance textiles and sportswear featuring its Planar Thermal Circuit® technology for thermal regulation, Grafysorber® for environmental remediation such as oil absorption, and Gipave®, a supermodifier for enhancing asphalt durability. The company's materials are also used in composites, footwear, and antimicrobial surfaces.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1375 characters) and is explicitly labeled with an 'RNS Number' and states that the information is provided by 'RNS, the news service of the London Stock Exchange.' The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, short-form regulatory announcement concerning market operations rather than a comprehensive financial report (like 10-K or IR) or a management change. Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIV, DIRS, or ER, the most appropriate classification is the general regulatory filing fallback category.
2020-04-14 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1358 characters) and begins with an 'RNS Number' (6094J), indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Price Monitoring Extension' for a security, which is a specific operational notice related to trading mechanisms. Since this is a general regulatory announcement that doesn't fit the specific categories like Director's Dealing (DIRS), Dividend (DIV), or Earnings Release (ER), and it is a direct notification via the RNS system, the most appropriate classification is the general Regulatory Filings category (RNS).
2020-04-14 English
Agreement with Iterchimica
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated April 14, 2020. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' The content details a new commercial agreement between Directa Plus plc and Iterchimica regarding the supply of graphene for asphalts. This structure—a brief announcement disseminated via the RNS system concerning a material business event (a new supply agreement)—fits the definition of a general regulatory announcement that doesn't correspond to a specific financial report (like 10-K, IR, or ER). Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (5121 chars) is substantial enough that it is not merely an announcement *about* a report, but the report itself (the announcement).
2020-04-14 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document contains an 'RNS Number' and explicitly states that the information is provided by 'RNS, the news service of the London Stock Exchange.' The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a type of market operational announcement. Since this is a general regulatory announcement disseminated via the RNS system and does not fit into specific categories like ER, 10-K, or DIV, the most appropriate classification is the general regulatory filing category.
2020-03-30 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1481 characters) and contains an RNS Number (0851I) and mentions the London Stock Exchange and the Financial Conduct Authority (FCA). The content describes a 'Price Monitoring Extension' for a security, which is a routine operational announcement related to trading mechanisms, not a core financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement distributed via the RNS service and does not fit into the more specific categories (like DIV, DIRS, or CT), the most appropriate classification is the general Regulatory Filings category (RNS).
2020-03-30 English
Covid-19 Update
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is explicitly stated to be information provided by 'RNS, the news service of the London Stock Exchange.' It contains a brief update regarding the company's operations during the COVID-19 emergency and its classification by the Italian Government. The length is short (3612 characters), and it functions as a general regulatory announcement rather than a detailed financial report (like 10-K or IR) or a specific corporate action notice (like DIV or CAP). Since it is a general regulatory announcement distributed via RNS and does not fit neatly into the more specific categories, the appropriate classification is Regulatory Filings (RNS).
2020-03-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.